NO20080722L - Use of 4- (3,4-dichlorophenyl) -1,2,3,4-tetrahydronaphthalen-1-ylamine for the treatment of cancer - Google Patents

Use of 4- (3,4-dichlorophenyl) -1,2,3,4-tetrahydronaphthalen-1-ylamine for the treatment of cancer

Info

Publication number
NO20080722L
NO20080722L NO20080722A NO20080722A NO20080722L NO 20080722 L NO20080722 L NO 20080722L NO 20080722 A NO20080722 A NO 20080722A NO 20080722 A NO20080722 A NO 20080722A NO 20080722 L NO20080722 L NO 20080722L
Authority
NO
Norway
Prior art keywords
treatment
tetrahydronaphthalen
ylamine
dichlorophenyl
cancer
Prior art date
Application number
NO20080722A
Other languages
Norwegian (no)
Inventor
Fabrice Balavoine
Frederic Revah
Marius Tuijnder
Robert Amson
Adam Telerman
Original Assignee
Anceris
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anceris filed Critical Anceris
Publication of NO20080722L publication Critical patent/NO20080722L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Oppfinnelsen angår bruken av 4-(3,4-diklor-fenyl)-1,2,3,4-tetrahydronaftalen-1-ylamin eller enhver kombinasjon av dens enantiomerer eller én av dens enantiomerer for fremstillingen av en farmasøytisk sammensetning for behandling av cancer, så vel som behandling og forebygging av metastaser.The invention relates to the use of 4- (3,4-dichlorophenyl) -1,2,3,4-tetrahydronaphthalen-1-ylamine or any combination of its enantiomers or one of its enantiomers for the preparation of a pharmaceutical composition for the treatment of cancer , as well as the treatment and prevention of metastases.

NO20080722A 2005-07-12 2008-02-08 Use of 4- (3,4-dichlorophenyl) -1,2,3,4-tetrahydronaphthalen-1-ylamine for the treatment of cancer NO20080722L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0507480A FR2888506A1 (en) 2005-07-12 2005-07-12 USE OF 4- (3,4-DICHLOROPHENYL) -1,2,3,4-TETRAHYDRO-NAPHTHALEN-1-YLAMINE FOR THE TREATMENT OF CANCER
PCT/EP2006/064155 WO2007006797A1 (en) 2005-07-12 2006-07-12 Use of 4-(3,4-dichloro-phenyl)-1,2,3,4-tetrahydro-naphtalen-1-ylamine for treating cancer

Publications (1)

Publication Number Publication Date
NO20080722L true NO20080722L (en) 2008-04-04

Family

ID=35925210

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080722A NO20080722L (en) 2005-07-12 2008-02-08 Use of 4- (3,4-dichlorophenyl) -1,2,3,4-tetrahydronaphthalen-1-ylamine for the treatment of cancer

Country Status (14)

Country Link
EP (1) EP1904045A1 (en)
JP (1) JP2009501193A (en)
KR (1) KR20080031748A (en)
CN (1) CN101222917A (en)
AU (1) AU2006268657A1 (en)
CA (1) CA2614696A1 (en)
FR (1) FR2888506A1 (en)
IL (1) IL188685A0 (en)
MA (1) MA29729B1 (en)
NO (1) NO20080722L (en)
RU (1) RU2008101268A (en)
TN (1) TNSN08010A1 (en)
WO (1) WO2007006797A1 (en)
ZA (1) ZA200800500B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2643602T3 (en) * 2006-03-31 2017-11-23 Sunovion Pharmaceuticals Inc. Amines and chiral
FR2909283A1 (en) * 2006-11-30 2008-06-06 Cerep Sa COMBINATION PRODUCT CONTAINING N-DESMETHYLSERTRALINE, OR ONE OF ITS SALT, AND AN ANNEOPLASTIC AGENT FOR THE TREATMENT OF CANCER
FR3071726B1 (en) * 2017-09-29 2020-09-04 Univ Paris Sud TCTP PROTEIN INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE AND INFECTIOUS DISEASES

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996022085A1 (en) * 1995-01-17 1996-07-25 Pfizer Inc. The use of sertraline to treat cancer patients
US20050013853A1 (en) * 2000-11-29 2005-01-20 Irit Gil-Ad Anti-proliferative drugs
BRPI0413679A (en) * 2003-08-22 2006-10-24 Pharmacia Corp formulations of a selective cyclooxygenase-2 inhibitor and a serotonin modulating agent for the treatment of neoplasia

Also Published As

Publication number Publication date
CN101222917A (en) 2008-07-16
RU2008101268A (en) 2009-08-20
ZA200800500B (en) 2009-04-29
TNSN08010A1 (en) 2009-07-14
KR20080031748A (en) 2008-04-10
EP1904045A1 (en) 2008-04-02
FR2888506A1 (en) 2007-01-19
IL188685A0 (en) 2008-12-29
AU2006268657A1 (en) 2007-01-18
JP2009501193A (en) 2009-01-15
MA29729B1 (en) 2008-09-01
WO2007006797A8 (en) 2007-04-19
CA2614696A1 (en) 2007-01-18
WO2007006797A1 (en) 2007-01-18

Similar Documents

Publication Publication Date Title
NO20091183L (en) Derivatives of 4- (N-azacycloalkyl) -anilides, processes for the preparation of such compounds, compositions comprising such compounds and the use of such compounds for the prevention or treatment of disease
NO20054083L (en) New interconnected triazolones and their use
NO20063449L (en) Substituted heterocycles and their use
ATE499372T1 (en) AZABENZIMIDALZOL DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ANTICANCER AGENTS
DK1487444T3 (en) Use of pyridylamides as angiogenesis inhibitors
WO2006106326A8 (en) Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors
WO2007095124A3 (en) Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors
PL1899329T3 (en) Pyrimidine-substituted benzimidazole derivatives as protein kinase inhibitors
EA201690265A3 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING SUBSTITUTED ACYLANILIDES
TW200738724A (en) Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
BRPI0709266B8 (en) 5-(hydroxymethylene and aminomethylene) substituted pyrimidines and pharmaceutical composition comprising them
CR8824A (en) DERIVATIVES OF 2-CARBAMIDA-4-FENILTIAZOL, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
ATE465719T1 (en) ORAL DISSOLVING COMPOSITION OF OLNZAPINE OR DONEPEZIL
NO20090596L (en) Antiviral phosphinate compounds
WO2006100081A3 (en) Substituted oxindole derivatives, medicaments containing the latter and use thereof
CL2007002757A1 (en) COMPOUNDS DERIVED FROM 1,2,4-SUBSTITUTED TRIAZINE; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OR PREVENTION OF GASTROESOFAGIC REFLUX AND ANXIETY.
DE602006006536D1 (en) Dry aripiprazole formulations
MX2009007345A (en) Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and uses thereof.
CL2009000906A1 (en) 4-imidazolyl and 4-triazolyl derivative compounds of 2- (6- (4-cycloalkylpiperazin-1-yl) pyrimidin-4-yl) -1h-pyrazol-3 (2h) one inhibitors of hif-prolyl-4-hydroxylases ; preparation procedure; pharmaceutical composition; and use of the compound in the treatment of cardiovascular, renal and hematological diseases.
NO20081160L (en) Benzimidazolthiophene Compounds
WO2007066336A3 (en) Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof
TW200616977A (en) Enantiomers of selected fused heterocyclics and uses thereof
NO20081014L (en) compositions
WO2007066337A3 (en) Jasmonate derivatives, pharmaceutical compositions and methods of use thereof
TW200745039A (en) Isotopically substituted pantoprazole

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application